BioReperia Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 16
Employees
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $835K
Latest Deal Amount
  • Investors
  • 7

BioReperia General Information

Description

Developer of a zebrafish technology platform designed to accelerate the process of drug discovery. The company's services offer zebrafish tumor xenograft models in which patients' tumor cells are implanted into zebrafish embryos in order to predict the most effective cancer treatment and facilitate identification of drug actions and toxicity, enabling pharmaceutical companies to increase precision reliability and the speed of pre-clinical development with increased success rate.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • Westmansgatan 47
  • Teknikringen 7, v.2
  • 582 16 Linköping
  • Sweden
+46 079-332 00 00

BioReperia Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioReperia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 22-May-2019 $835K 00.000 Completed Generating Revenue
4. Grant 01-Mar-2019 00.000 00000 Completed Generating Revenue
3. Grant 05-Oct-2017 00000 00000 Completed Generating Revenue
2. Early Stage VC 29-Jun-2017 $230K $230K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view BioReperia’s complete valuation and funding history, request access »

BioReperia Executive Team (6)

Name Title Board Seat Contact Info
Annika Ericson Chief Executive Officer
Anna Erkstam Ph.D Chief Operating Officer
Lasse Jensen Ph.D Co-Founder, Chief Technology Officer & Board Member
Malin Vildevall Ph.D Chief Scientific Officer
Anna Fahlgren Founder
You’re viewing 5 of 6 executive team members. Get the full list »

BioReperia Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioReperia Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Almi Invest Venture Capital Minority 000 0000 000000 0
Hemex Venture Capital Minority 000 0000 000000 0
LEAD Incubator Accelerator/Incubator Minority 000 0000 000000 0
Linköping University Other Minority 000 0000 000000 0
Vinnova Government Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »